HLA-DRB1 0401 and HLA-DRB1 0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis

Cepok, S.S.CepokHoffmann, S.S.HoffmannGrummel, V.V.GrummelLehmann-Horn, K.K.Lehmann-HornHackermüller, J.J.HackermüllerStadler, P.F.P.F.StadlerHartung, H.-P.H.-P.HartungBerthele, A.A.BertheleDeisenhammer, F.F.DeisenhammerWasmuth, R.R.WasmuthHemmer, B.B.Hemmer2022-03-042022-03-042008https://publica.fraunhofer.de/handle/publica/217065en610616HLA-DRB1 0401 and HLA-DRB1 0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosisjournal article